UBS has turned bullish on Rivian. CNBC and Investing.com report that analyst Joseph Spak upgraded the stock to Buy with a $17 price target.

The case

  • R2 demand: Spak points to demand for the smaller, cheaper R2.
  • Margins: UBS sees the margin outlook improving.
  • Cash: Rivian has about $13 billion in capital, and UBS doesn't think it needs to raise more before 2029.
  • Catalysts: an Autonomy day in December and an Autonomy+ launch in early 2027.

Context

The $17 target implies about 40% upside. Rivian shares had fallen about 20% over the previous three months. Jefferies upgraded the stock last week, and CNBC says 16 of the 28 analysts tracked by LSEG now rate it Buy.

This is a summary of analyst views, not investment advice.